Back to Results
First PageMeta Content
Pharmaceutical industry / Clinical research / Pharmacology / Food and Drug Administration / Good manufacturing practice / Pharmacovigilance / Postmarketing surveillance / Health Products and Food Branch / Adverse effect / Medicine / Health / Pharmaceutical sciences


Microsoft Word - Human Drugs Program Evaluation Final May 2014.docx
Add to Reading List

Document Date: 2014-09-04 14:54:11


Open Document

File Size: 769,03 KB

Share Result on Facebook

Company

Good Guidance Practices Good Manufacturing Practices Government of Canada Good Review / Health Canada / Public Health Agency of Canada Evaluation Report SEB / CTA-A CTD / /

Country

United States / Canada / China / India / /

Facility

Institute of Medicine Look alike/sound / /

IndustryTerm

foreign manufacturing sites / supply chain / blood products / data-mining / active pharmaceutical ingredients / generic manufacturer / food / pharmaceutical ingredient / regulatory services / counterfeit health products / health products / pharmaceutical drugs / therapeutic products / combination products / drug products / /

Organization

Institute of Medicine Look alike/sound / Public Health Agency / Public Health Agency of Canada Evaluation Report SEB SIMS SNDS / World Health Organization / Food and Drug Administration / Canada Evaluation Report HECSB HESA HPFB ICH IOM LA/SA MAH MHPD MHRA MOU MRA NAS NC NDS NIH NMI NOC NOC/c NOL OAG OCS ORS OTC PAA PAAT PBRER PDP PEAC PHAC PIC/S PLR PMRC PMS PPIAD PSUR PVP Q&A RAPB RCC REB REMS RMOD RMP SAC SANDS SAP SBD Healthy Environments and Consumer Safety Branch House of Commons Standing Committee on Health Health Products and Food Branch International Conference / Canadian Institute / Policy / Planning and International Affairs Directorate / Public Health Agency of Canada / Therapeutic Goods Administration / Public Health Agency of Canada Evaluation Report List / Public Health Agency of Canada Evaluation Report Table of Contents Executive Summary / Good Clinical Practices Good Guidance Practices Good Manufacturing Practices Government of Canada Good Review Practices Good Pharmacovigilance Practices Human Drugs Program Evaluation of the Human Drugs Program / Food Inspection Agency / Stakeholder Information Management System Supplemental New Drug Submission Standard Operating Procedure Senate Standing Committee on Social Affairs / Science and Technology Therapeutic Access Strategy Therapeutic Goods Administration Therapeutic Products Directorate Therapeutic Product Safety Initiative World Health Organization Evaluation / Public Health Agency of Canada Evaluation Report In / Biologics and Genetic Therapies Directorate Bilateral Meeting Program Canada Border Services Agency Canadian Centre on Substance Abuse Centres for Disease Control Controlled Drugs / Canada Office / Health Products and Food Branch / Conditions No Objection Letter office of the Auditor General / federal government / Therapeutic Products Directorate / FDA / Regions and Programs Bureau / Public Health Agency of Canada Evaluation Report / European Union / Regulatory Cooperation Council / Medicines and Healthcare Products Regulatory Agency / Public Health Agency of Canada Evaluation Report HECSB HESA HPFB ICH IOM LA/SA MAH MHPD MHRA MOU MRA NAS NC NDS NIH NMI NOC NOC/c NOL OAG OCS ORS OTC PAA PAAT PBRER PDP PEAC PHAC PIC/S PLR PMRC PMS PPIAD PSUR PVP Q&A RAPB RCC REB REMS RMOD RMP SAC SANDS SAP SBD Healthy Environments / Resource Management and Operations Directorate / Controlled Substances office of Research and Surveillance / Marketed Health Products Directorate / /

Person

ANDS API BGTD / SSCSAST TAS TGA TPD TPSI / DHPL DIN DPD DPR DSEN EAC / /

Position

FTE GCP GGP GMP GoC GRP GVP HDP Assistant Deputy Minister / Canada Pharmaceutical Inspection Cooperation Scheme Physician / Executive / CTO / /

Product

Database Departmental Performance Report Drug / /

Technology

BMP / /

SocialTag